Tag - TLX

Developments

Profound Medical and Telix Pharmaceuticals enter co-education agreement to advance PSMA-informed, MRI-guided and incisionless prostate care

Profound Medical (NASDAQ:PROF; TSX:PRN) and Telix Pharmaceuticals (ASX:TLX; NASDAQ:TLX) have entered into a co-education agreement which establishes a framework through which the companies intend to educate urologists...

October 9, 2026

Developments

Telix in PSMA collaboration with Profound Medical and other prostate cancer therapy players

Telix Pharmaceuticals (ASX:TLX, NASDAQ:TLX) announced that it has entered into letters of intent to pursue collaborations to explore the investigational use of its PSMA-PET imaging agents Gozellix (kit for the...

May 15, 2026

Tag - TLX

Profound Medical and Telix Pharmaceuticals enter co-education agreement to advance PSMA-informed, MRI-guided and incisionless prostate care

Telix in PSMA collaboration with Profound Medical and other prostate cancer therapy players

Subscribe